About BioRay Pharmaceutical
BioRay Pharmaceutical is a company based in Taizhou (China) founded in 2019 was acquired by PAG in September 2019.. BioRay Pharmaceutical has raised $214.97 million across 1 funding round from investors including PAG. BioRay Pharmaceutical operates in a competitive market with competitors including Moderna, BeiGene, Incyte, Horizon Therapeutics and Forge Biologics, among others.
- Headquarter Taizhou, China
- Stage Unicorn
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Bioray Pharmaceutical Corp
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Unlock access to complete
Unlock access to complete
Funding Insights of BioRay Pharmaceutical
BioRay Pharmaceutical has successfully raised a total of $214.97M through 1 strategic funding round. The most recent funding activity was a Series D round of $214.97 million completed in December 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Series D — $215.0M
-
First Round
First Round
(29 Dec 2022)
- Investors Count Investors Count
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec, 2022 | Amount | Series D - BioRay Pharmaceutical | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in BioRay Pharmaceutical
BioRay Pharmaceutical has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include PAG. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Alternative investment firm
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by BioRay Pharmaceutical
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - BioRay Pharmaceutical
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Bioray Pharmaceutical Comparisons
Competitors of BioRay Pharmaceutical
BioRay Pharmaceutical operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Moderna, BeiGene, Incyte, Horizon Therapeutics and Forge Biologics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
mRNA-based therapeutics for diseases including cancer and infections are developed.
|
|
| domain | founded_year | HQ Location |
Targeted and immune-oncology drugs for cancer treatment are developed.
|
|
| domain | founded_year | HQ Location |
Small molecules are developed for cancer and skin disease treatments.
|
|
| domain | founded_year | HQ Location |
Developer of drugs for treating rare and autoimmune diseases
|
|
| domain | founded_year | HQ Location |
Gene therapies for rare diseases are developed to treat patients.
|
|
| domain | founded_year | HQ Location |
Therapeutic antibodies for cancer and other diseases are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Bioray Pharmaceutical
Frequently Asked Questions about BioRay Pharmaceutical
When was BioRay Pharmaceutical founded?
BioRay Pharmaceutical was founded in 2019 and raised its 1st funding round 3 years after it was founded.
Where is BioRay Pharmaceutical located?
BioRay Pharmaceutical is headquartered in Taizhou, China. It is registered at Taizhou, Jiangsu, China.
Who is the current CEO of BioRay Pharmaceutical?
Haibin Wang is the current CEO of BioRay Pharmaceutical.
Is BioRay Pharmaceutical a funded company?
BioRay Pharmaceutical is a funded company, having raised a total of $214.97M across 1 funding round to date. The company's 1st funding round was a Series D of $214.97M, raised on Dec 29, 2022.
What does BioRay Pharmaceutical do?
BioRay Pharmaceutical was founded in 2019 in Taizhou, China, within the biotechnology sector. Therapeutics are developed using an antibody-technology platform targeted at immune-mediated diseases, including rheumatoid arthritis, psoriasis, and Ankylosing Spondylitis. Drugs for cancer and tumors are also offered. Formulated products derived from organic ingredients are provided to support health restoration and bodily balance. Operations focus on immunology and oncology research and development.
Who are the top competitors of BioRay Pharmaceutical?
Who are BioRay Pharmaceutical's investors?
BioRay Pharmaceutical has 1 investor. Key investors include PAG.
What is BioRay Pharmaceutical's valuation?
The valuation of BioRay Pharmaceutical is $1.9B as of Dec 2022.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.